Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Yoichi Aoki

15PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Ecological applications not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|Apr 09, 2026
Prevalence and clinicopathologic features of mismatch repair-deficient endometrial cancer in Japanese patients younger than 50 years: a single-center prospective observational study.

Hidetaka Nomura, Akiko Abe, Atsushi Fusegi

|Mar 30, 2026
Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer.

Yusuke Toyohara, Mayu Yunokawa, Ryo Nimura

|Jan 28, 2026
Surgical Timing and Survival in Advanced High-Grade Serous Ovarian Cancer in the PARP Inhibitor Era.

Motoko Kanno, Atsushi Fusegi, Naoki Miyazaki

|Mar 31, 2025
Long-term conservative treatment of chylous ascites in gynecological malignant surgery: a case report and literature review.

Mayumi Kamata, Yoichi Aoki, Ai Ikki

|Feb 01, 2025
Comparison of the incidence of vaginal cuff dehiscence by hysterectomy route and type based on experienced surgeons' outcome.

Ai Ikki, Yoichi Aoki, Motoko Kanno

|Dec 06, 2024
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience.

Mayu Yunokawa, Akiko Abe, Xiaofei Wang

Pageof 3

Frequent Collaborators

10 joint publications

Hiroyuki Kanao

10 joint publications

Atsushi Fusegi

9 joint publications

Hidetaka Nomura

7 joint publications

Mayu Yunokawa

7 joint publications

Makiko Omi

5 joint publications

Terumi Tanigawa

5 joint publications

Sanshiro Okamoto

5 joint publications

Akiko Abe

5 joint publications

Sachiho Netsu

5 joint publications

Motoko Kanno

Frequent Collaborators

10 joint publications

Hiroyuki Kanao

10 joint publications

Atsushi Fusegi

9 joint publications

Hidetaka Nomura

7 joint publications

Mayu Yunokawa

Top Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

12.8K
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

3.3K
Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
07:19

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids

Published on : Jan 06, 2023

5.3K
See more related videos

Top Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

12.8K
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

3.3K
Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
07:19

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids

Published on : Jan 06, 2023

5.3K
See more related videos